Maxim Group Has Lowered Expectations for Cryo-Cell International (NYSEAMERICAN:CCEL) Stock Price

Cryo-Cell International (NYSEAMERICAN:CCEL - Get Free Report) had its target price dropped by Maxim Group from $9.00 to $8.50 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a "buy" rating on the stock. Maxim Group's price target points to a potential upside of 18.55% from the company's previous close.

Cryo-Cell International Stock Up 2.0 %

Shares of CCEL stock traded up $0.14 during trading hours on Tuesday, reaching $7.17. The company had a trading volume of 6,844 shares, compared to its average volume of 12,541. The firm has a market capitalization of $57.79 million, a PE ratio of -6.76 and a beta of 0.53. Cryo-Cell International has a 12 month low of $5.35 and a 12 month high of $9.50.

Institutional Trading of Cryo-Cell International

Large investors have recently bought and sold shares of the company. Topline Capital Management LLC purchased a new position in shares of Cryo-Cell International in the fourth quarter valued at $354,000. Geode Capital Management LLC grew its position in shares of Cryo-Cell International by 68.5% in the third quarter. Geode Capital Management LLC now owns 39,860 shares of the company's stock valued at $254,000 after purchasing an additional 16,203 shares in the last quarter. Northern Trust Corp grew its position in shares of Cryo-Cell International by 78.2% in the fourth quarter. Northern Trust Corp now owns 38,902 shares of the company's stock valued at $288,000 after purchasing an additional 17,066 shares in the last quarter. Heron Bay Capital Management purchased a new position in shares of Cryo-Cell International in the fourth quarter valued at $235,000. Finally, CreativeOne Wealth LLC purchased a new position in shares of Cryo-Cell International in the fourth quarter valued at $113,000. 10.44% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.